Claims for Patent: 9,486,483

Summary for Patent: 9,486,483

Title:	Bone grafts including osteogenic stem cells, and methods relating to the same
Abstract:	Bone grafts and constructs including stem cells are provided. Example bone grafts include osteogenic stem cells seeded on a scaffold of osteoconductive cortico-cancellous chips and/or osteoinductive demineralized bone. Example constructs include extracellular matrix on a synthetic scaffold, in which the ECM is secreted from MSCs seeded onto the synthetic scaffold. Also provided are methods of making the present bone grafts and scaffolds. Further provided are methods of promoting bone healing and treating wound healing, by administering the present bone grafts and constructs to a mammal in need thereof. Also provided are kits that include the present bone grafts and/or constructs, or components thereof.
Inventor(s):	Bhat; Archana (Royersford, PA), Rao; Shairali (Austin, TX), Laskowitz; Daniel (Lancaster, PA)
Assignee:	Globus Medical, Inc. (Audobon, PA)
Application Number:	14/057,860
Patent Claims:	1. A bone graft having viable cells, the bone graft comprising: a mixture of non-demineralized cortico-cancellous chips and demineralized cortical bone which form a scaffold without an additional natural or synthetic material, the cortico-cancellous chips obtained from condyles and the demineralized cortical bone obtained from cortical shafts of long bones; and osteogenic stem cells seeded on the scaffold to form the bone graft having viable cells capable of bone regeneration, wherein the osteogenic stem cells are obtained from cells cultured from a mixture of bone marrow and cells from cancellous bone treated with collagenase. 2. The bone graft of claim 1, wherein the scaffold consists of a mixture of demineralized bone matrix and cortico-cancellous chips in a ratio of about 1:1. 3. The bone graft of claim 1, wherein the long bones include one or more of a femur, tibia, and humerus. 4. The bone graft of claim 1, wherein the osteogenic stem cells are present in the bone graft in an amount of at least 20,000 cells/cc. 5. The bone graft of claim 1, wherein the cells from cancellous bone are obtained by treating cancellous bone from a femur or tibia with collagenase and separating loosely attached cells by centrifugation. 6. The bone graft of claim 1, wherein the demineralized cortical bone and the non-demineralized cortico-cancellous chips are present in a ratio of about 1:1, 1:2 or 1:3. 7. The bone graft of claim 1, wherein the bone marrow is harvested from an iliac crest. 8. The bone graft of claim 1, wherein the osteogenic stem cells are seeded on the scaffold such that the bone graft has a seeding density of 20,000 to 100,000 cells/cm.sup.2. 9. The bone graft of 1, wherein the osteogenic stem cells are mesenchymal stem cells. 10. The bone graft of claim 9, wherein the mesenchymal stem cells are derived from bone marrow, cancellous bone, or a mixture thereof. 11. The bone graft of claim 9, wherein the mesenchymal stem cells are derived from a human source. 12. The bone graft of claim 9, wherein the mesenchymal stem cells are derived from a bovine source. 13. The bone graft of claim 1, wherein the bone graft has a putty-like consistency.

Details for Patent 9,486,483

Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Smith & Nephew, Inc.	SANTYL	collagenase	Ointment	101995	06/04/1965		2039-03-29